Skip to navigation menu Skip to content
Informational Alert


B Cell Biology and Engineering

Finding factors important for differentiation of antibody-secreting cells will help us engineer a B cell therapy for protein replacement or treat antibody-mediated disease.


The goal of the lymphoma group is to identify drugs that can be combined with existing therapies to prevent or mitigate drug resistance.

Functional Interpretation of Variants in Immune Genes

We are building low- and high-throughput assays to study the function of variants in B cell-related to help improve the diagnosis and treatment of immunological disease.

Our Methods

We use quantitative proteomics, gene editing, next generation sequencing, flow cytometry, murine modeling, and computational approaches to accomplish our experimental goals.


Richard James

For questions or inquiries, 206. 884. 3290


James Lab
1900 9th Avenue
Seattle, WA 98101

By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.

Accept All Cookies